查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1919261

氟化物泡沫市场：按产品类型、应用方式、最终用户和分销管道划分 - 2026-2032年全球预测

Fluoride Foam Market by Product Type, Application Mode, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025年氟化物泡沫市值为1.3963亿美元，预计到2026年将成长至1.5593亿美元，年复合成长率为7.05%，到2032年将达到2.2498亿美元。

关键市场统计数据
基准年 2025 1.3963亿美元
预计年份：2026年 1.5593亿美元
预测年份 2032 2.2498亿美元
复合年增长率 (%) 7.05%

重点介绍氟化物泡沫的临床作用、配方特性及其在现代预防牙科的应用优势

随着临床医生和护理人员寻求兼顾疗效、患者舒适度和操作效率的高效局部氟化方法，氟化物泡沫在预防牙科领域正发挥日益重要的战略作用。本文概述了氟化物泡棉作为局部预防措施的基本特性和临床原理，重点介绍了其在临床工作流程中的作用，并阐述了临床医生在选择用于常规和针对性护理的配方时应考虑的产品差异。

临床实务、监管和管理技术的变革性趋势正在重塑氟化物泡沫剂的应用和供应策略。

随着临床证据、患者偏好和采购重点围绕效率、安全性和差异化产品性能进行调整，局部氟化物给药领域正在改变。技术进步，例如改进的泡沫稳定剂和精密分配器，使得产品能够减少操作者差异，并更稳定地输送治疗浓度的氟化物。同时，人们越来越重视缩短诊疗时间和降低交叉感染风险的方法，这促使人们对与一次性托盘相容且简化冲洗程序的泡沫剂型产生了兴趣。

分析2025年美国关税对牙科耗材供应链、定价策略和采购惯例的累积影响

美国2025年实施的关税政策调整为牙科耗材供应链中的相关人员带来了新的挑战，其中包括氟化物泡棉组件和成品。依赖进口的製造商和经销商重新评估了筹资策略以适应成本结构的变化，采购团队则寻求透过寻找替代供应商、近岸外包以及建立战略库存缓衝来降低风险。这些战术性调整通常需要重新谈判供应商合约并调整前置作业时间週期，以确保临床客户的供应不间断。

全面的細項分析揭示了产品变体、分销管道、终端用户群体和应用模式如何影响临床应用和商业性重点。

细分市场分析揭示了不同产品类型、分销管道、终端用户群和应用方法的需求驱动因素各不相同，这些因素会影响消费者的选择决策和商业性优先事项。在产品类型内部，又可细分为防龋泡棉、抗敏泡棉和一般泡棉市场，每种泡棉都服务不同的临床目的：防龋配方着重于牙齿再矿化，抗敏产品针对牙本质过敏途径，而一般泡棉则提供一般的预防功效。活性成分浓度和添加剂组成的差异会影响医疗保健专业人员的选择，取决于治疗目标和患者的敏感性。

美洲、欧洲、中东和非洲以及亚太地区的主要区域趋势将影响监管、分销和商业性执行。

区域趋势影响临床实践模式、监管预期和供应链设计，对製造商和经销商都具有重大影响。在美洲，完善的牙科预防项目、广泛的支付方和机构采购框架以及成熟的零售药房网络，为多样化的分销模式提供了支持，并强调临床疗效检验和品牌差异化。在该地区运营的製造商通常专注于临床医生教育、报销协调和物流效率，以同时服务机构客户和零售通路。

竞争洞察：临床证据、经销伙伴和营运灵活性将如何决定氟化物泡沫製造商的成功

氟化物泡棉市场的竞争格局由成熟的牙科耗材製造商、专业口腔清洁用品品牌以及凭藉配方创新、临床支援和供应链应对力脱颖而出的灵活区域性企业组成。主要企业优先考虑临床证据的积累，并投资于现场培训，以建立与牙科专业人士的信任。这些措施包括支持继续教育、提供诊所内培训模组以及製定临床通讯协定，将氟化物泡沫整合到全面的龋病管理策略中。

为製造商和经销商提供实用建议，以增强临床应用、提高供应链韧性并实施通路特定的商业执行

在临床偏好不断变化、监管审查日益严格、采购流程日益复杂的环境下，产业领导者应优先采取行动，加速产品应用并增强自身韧性。首先，应投资严谨的临床合作项目，以证明其在不同患者群体和应用情境下的治疗价值。这些项目应以同行评审的证据和实际案例研究为支撑，展现真实世界的临床疗效。这种临床可信度能够为医护人员建立信任，并有助于将其纳入医疗机构的采购架构。

采用透明的调查方法，结合医疗专业人员访谈、监管审查和供应链分析，以检验洞察和策略意义。

本分析结合了一手和二手研究，对产品特性、分销通路趋势和相关人员的优先事项进行了三角验证。一手研究包括对临床医生、牙科诊所采购主管和分销经理的结构化访谈，以及对临床和零售环境中应用流程的现场观察。二级资讯来源包括同行检验的临床文献、监管指导文件以及专业协会发布的指南局部氟化物安全有效使用的立场声明。

综合分析表明，临床证据、供应链韧性和通路特定策略将决定氟化物泡沫的未来。

总体而言，氟化物泡沫在预防牙科领域占据着战略地位，因为它兼顾了临床疗效、患者接受度和操作效率。其推广应用受到配方和给药系统不断改进、监管机构日益重视安全性和标籤以及满足不同通路和人群需求的商业性因素的影响。将产品开发与临床医生实践模式和通路要求相结合的相关人员将更有利于确保产品的持续推广应用。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依产品类型分類的氟化物泡棉市场

  • 防蛀泡沫
  • 敏感牙齿泡沫
  • 正规形式

9. 按应用分類的氟化物泡沫市场

  • 可水洗型
  • 托盘系统

第十章 以最终用户分類的氟化物泡沫市场

  • 成人版
  • 对于老年人
  • 儿童

第十一章 氟化物泡棉市场（依分销通路划分）

  • 牙科医院和牙科诊所
  • 药局和药房
  • 网路商店

12. 各地区氟化物泡沫市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 氟化物泡沫市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国氟化物泡沫市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国氟化物泡沫市场

第十六章：中国氟化物泡沫市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • 3M Company
  • Centrix, Inc.
  • Chengdu I-ReHealth Medical Devices Co., Ltd
  • Dentsply Sirona Inc.
  • DMG Dental
  • GC Corporation
  • Henry Schein, Inc.
  • Laclede Products Company
  • MEDICOM Group
  • Ross Healthcare
  • Sultan Healthcare, Inc.
  • Ultradent Products, Inc.
  • VOCO GmbH
  • Young Dental Manufacturing Limited
Product Code: MRR-F14BA1B34171

The Fluoride Foam Market was valued at USD 139.63 million in 2025 and is projected to grow to USD 155.93 million in 2026, with a CAGR of 7.05%, reaching USD 224.98 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 139.63 million
Estimated Year [2026] USD 155.93 million
Forecast Year [2032] USD 224.98 million
CAGR (%) 7.05%

A focused introduction to fluoride foam's clinical role, formulation characteristics, and operational advantages for modern preventive dental care

The fluoride foam segment plays an increasingly strategic role in preventive dentistry as clinicians and care providers seek efficient topical fluoridation approaches that balance efficacy, patient comfort, and operational throughput. This introduction outlines the essential properties and clinical rationale of fluoride foam as a topical preventive modality, highlights where it fits within practice workflows, and explains the product variants clinicians consider when selecting a formulation for routine and targeted care.

Beginning with formulation fundamentals, fluoride foam delivers active fluoride ions via low-viscosity carriers designed to maximize surface contact with enamel while minimizing ingestion risk. The regimen advantages extend to rapid application protocols suitable for both tray-based and rinse-off methods, enabling easy integration into diverse practice settings. Clinicians value foam options for their ease of portioning and reduced material wastage relative to gels, and administrators appreciate the operational efficiencies in high-volume environments. As a preventive tool, fluoride foam complements broader oral health strategies, supporting caries management plans that range from primary prevention in pediatric care to targeted remineralization in adult and geriatric patients. Throughout this report, the discussion underscores practical considerations for adoption, including compatibility with existing dental operatory flows, practitioner training requirements, and patient acceptability factors that influence routine use.

Transformative trends in clinical practice, regulatory scrutiny, and delivery technology reshaping fluoride foam adoption and supplier strategies

The landscape for topical fluoride delivery is shifting as clinical evidence, patient preferences, and procurement priorities realign around efficiency, safety, and differentiated product performance. Technological refinements in delivery systems, including improved foam stabilizers and precision-dispensing applicators, have enabled manufacturers to offer products that reduce operator variability and consistently deliver therapeutic fluoride doses. Concurrently, clinicians are reassessing protocols to favor modalities that shorten chair time and lower cross-contamination risk, which has elevated interest in foam formats that pair well with single-use trays and simplified rinse-off routines.

Beyond formulation and delivery advances, market dynamics are influenced by evolving regulatory focus on ingredient transparency and adverse event reporting, prompting suppliers to optimize labeling and invest in clinician education. Patient-driven trends also matter: greater emphasis on minimally invasive dentistry and convenient care models has increased demand for topical agents that are perceived as safe and easy to use across age cohorts. In addition, digital-enabled procurement and telehealth consultations are reshaping how practices source products and validate clinical choices, so manufacturers that provide robust clinical support materials and digital resources gain a competitive edge. Collectively, these shifts are reorienting investment toward product quality, clinician training, and supply-chain resilience to meet the changing expectations of providers and patients alike.

Analysis of the cumulative effects of 2025 U.S. tariff measures on supply chains, pricing strategies, and procurement practices for dental consumables

U.S. tariff policy adjustments implemented in 2025 have created a new layer of complexity for stakeholders involved in the supply chain of dental consumables, including fluoride foam components and finished goods. Import-dependent manufacturers and distributors reassessed sourcing strategies in response to altered cost structures, with procurement teams exploring alternative suppliers, nearshoring options, and strategic inventory buffers to mitigate exposure. These tactical shifts often required renegotiation of supplier contracts and adjustments to lead times to maintain uninterrupted supply to clinical customers.

Moreover, the tariffs prompted a reevaluation of product pricing strategies across the value chain. Manufacturers absorbing cost increases selectively adjusted list prices while prioritizing key accounts and long-term customers through contractual protections or promotional allowances. Distributors and large institutional buyers leveraged purchasing power to secure multi-period agreements that softened short-term cost volatility, while smaller buyers faced tighter margins and heightened sensitivity to price changes. In parallel, some players accelerated investments in local manufacturing capabilities or diversified raw material sourcing to reduce reliance on tariff-affected imports. Overall, the cumulative impact was a recalibration of supply-chain resilience and commercial playbooks, encouraging greater transparency in cost drivers and a renewed emphasis on operational flexibility.

Comprehensive segmentation insights revealing how product variants, channels, end-user cohorts, and application modes shape clinical adoption and commercial focus

Segmentation analysis illuminates nuanced demand drivers across product types, distribution channels, end-user demographics, and application modes that shape deployment decisions and commercial priorities. Based on product type, the market encompasses Anticavity Foam, Desensitizing Foam, and Regular Foam, each serving distinct clinical objectives: anticavity formulations emphasize remineralization, desensitizing variants target dentin hypersensitivity pathways, and regular foam offers general preventive coverage. Differences in active concentration and excipient profiles influence practitioner selection depending on treatment goals and patient sensitivity.

Based on distribution channel, the market is supplied through Dental Hospitals & Clinics, Drugstores & Pharmacies, and Online Stores, each channel presenting unique service expectations and procurement cycles. Clinics prioritize bulk purchasing aligned with clinical protocols and recurring consumption, retail pharmacies cater to over-the-counter convenience and consumer-facing packaging, while online stores support direct-to-consumer models and subscription fulfillment. Based on end user, patient cohorts include Adult, Geriatric, and Pediatric segments; each cohort imposes different formulation and delivery considerations related to fluoride tolerance, compliance, and caregiver involvement. Based on application mode, clinicians and patients use either a Rinse-Off System or Tray System, with each mode bringing trade-offs in contact time, ease of use, and suitability for specific clinical scenarios. By integrating these segmentation lenses, stakeholders can better align product development, marketing, and distribution tactics to the differentiated needs of providers and patients.

Key regional dynamics across the Americas, Europe Middle East & Africa, and Asia-Pacific that influence regulation, distribution, and commercial execution

Regional dynamics influence clinical practice patterns, regulatory expectations, and supply-chain design in ways that matter to manufacturers and distributors alike. In the Americas, established preventive dentistry programs, broad insurer and institutional procurement frameworks, and a mature retail pharmacy network support diversified distribution models and emphasize clinical validation and branded differentiation. Manufacturers operating here often concentrate on clinician education, reimbursement alignment, and logistics efficiency to service both high-volume institutional buyers and retail channels.

Across Europe, Middle East & Africa, regulatory harmonization efforts and heterogeneous care delivery systems create a complex operating environment where localized registration requirements and varying procurement practices require tailored market entry strategies. Suppliers in this region frequently invest in local partnerships and regional regulatory expertise to navigate differing standards and to adapt packaging and labeling to multiple languages and compliance regimes. In Asia-Pacific, rising access to dental care, expanding private practice footprints, and growing e-commerce adoption are driving demand for convenient topical solutions. Competitive dynamics in this region place a premium on cost-effective manufacturing, flexible packaging formats for diverse retail environments, and strong digital marketing to reach both professional buyers and direct-to-consumer channels. Understanding these regional contrasts enables targeted commercial plans and resource allocation that reflect local clinical priorities and distribution realities.

Competitive landscape insights highlighting how clinical evidence, distribution partnerships, and operational agility determine success for fluoride foam manufacturers

Competitive dynamics in the fluoride foam space are shaped by a mix of established dental consumables manufacturers, specialty oral care brands, and agile regional players that differentiate through formulation innovation, clinician support, or supply-chain responsiveness. Leading firms prioritize clinical evidence generation and invest in field-based education to build trust with dental professionals. These activities include sponsorship of continuing education, in-practice training modules, and the development of clinical protocols that integrate fluoride foam into broader caries management strategies.

Smaller and regional companies often compete on manufacturing flexibility, faster product iteration, and localized service levels that appeal to clinics with specific procurement preferences. Strategic partnerships between manufacturers and distributors can unlock channel-specific capabilities, such as pharmacy listing agreements or integrated logistics for institutional buyers. Additionally, the competitive posture of manufacturers is increasingly defined by their ability to provide digital resources, such as application guides and patient education materials, which facilitate adoption and strengthen brand recognition. In aggregate, competitive advantage accrues to companies that combine robust clinical support with operational excellence and channel-tailored commercial execution.

Actionable recommendations for manufacturers and distributors to strengthen clinical adoption, supply-chain resilience, and channel-specific commercial execution

To succeed in a landscape marked by evolving clinical preferences, regulatory scrutiny, and procurement complexity, industry leaders should pursue a set of prioritized actions that enhance adoption and resilience. First, invest in rigorous clinical engagement programs that demonstrate therapeutic value across patient cohorts and application modes, supported by peer-reviewed evidence and practical case studies demonstrating real-world outcomes. This clinical credibility acts as a foundation for provider trust and facilitates inclusion in institutional procurement frameworks.

Second, strengthen supply-chain flexibility by diversifying suppliers for key raw materials and evaluating nearshoring options where feasible to reduce exposure to tariff-induced disruptions. Complement these sourcing moves with inventory optimization tactics and transparent communication with key accounts to maintain continuity. Third, tailor commercial strategies to distribution channel nuances by offering clinic-centric packaging and contractual terms for dental hospitals and clinics, consumer-friendly pack formats for drugstores and pharmacies, and seamless digital shopping experiences for online buyers. Fourth, prioritize product design that accommodates age-specific needs across adult, geriatric, and pediatric users, and ensure clear guidance for both rinse-off and tray-based application modes. Finally, enhance post-market surveillance and regulatory readiness by strengthening adverse event monitoring and adapting labeling to regulatory expectations, thereby reducing friction in market entry and sustaining clinician confidence.

Transparent research methodology combining practitioner interviews, regulatory review, and supply-chain analysis to validate insights and strategic implications

This analysis synthesizes primary and secondary research streams to triangulate insights on product characteristics, channel behaviors, and stakeholder priorities. Primary inputs included structured interviews with practicing clinicians, procurement leads at dental institutions, and distribution managers, complemented by field observations of application workflows in clinical and retail settings. Secondary sources encompassed peer-reviewed clinical literature, regulatory guidance documents, and professional association position statements that inform safe and effective topical fluoride use.

Analytic methods prioritized cross-validation across data sources to ensure robust conclusions. Qualitative findings from practitioner interviews were reconciled with observational data and regulatory texts to identify consistent themes related to formulation preferences, application mode choices, and procurement considerations. The study also incorporated a supply-chain lens by mapping typical material flows and assessing sensitivity to tariff and logistical shocks. Wherever applicable, sensitivity checks and scenario analyses were used to test the robustness of strategic implications. Throughout, transparency in methodological assumptions and source attribution was maintained to support reproducibility and to enable clients to interrogate findings against their own operational contexts.

Concluding synthesis on how clinical evidence, supply-chain resilience, and channel-focused strategies will determine fluoride foam's trajectory

The concluding perspective emphasizes that fluoride foam occupies a strategic niche within preventive dentistry by offering a balance of clinical effectiveness, patient acceptability, and operational efficiency. Its adoption is being shaped by continuous improvements in formulation and delivery systems, heightened regulatory attention to safety and labeling, and the commercial imperative to serve diverse channels and demographic cohorts. Stakeholders who align product development with clinician practice patterns and channel requirements are best positioned to capture durable adoption.

Looking ahead, sustained focus on clinical evidence, supply-chain resilience, and channel-specific value propositions will determine which products gain traction. Manufacturers that harmonize these elements-while maintaining transparent engagement with regulatory authorities and delivering consistent educational support to clinicians-will strengthen trust and operational continuity. The conclusion thus calls for an integrated approach that combines scientific rigor, commercial dexterity, and logistical foresight to realize the full potential of fluoride foam within modern oral health strategies.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Fluoride Foam Market, by Product Type

  • 8.1. Anticavity Foam
  • 8.2. Desensitizing Foam
  • 8.3. Regular Foam

9. Fluoride Foam Market, by Application Mode

  • 9.1. Rinse-Off System
  • 9.2. Tray System

10. Fluoride Foam Market, by End User

  • 10.1. Adult
  • 10.2. Geriatric
  • 10.3. Pediatric

11. Fluoride Foam Market, by Distribution Channel

  • 11.1. Dental Hospitals & Clinics
  • 11.2. Drugstores & Pharmacies
  • 11.3. Online Stores

12. Fluoride Foam Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Fluoride Foam Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Fluoride Foam Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Fluoride Foam Market

16. China Fluoride Foam Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. 3M Company
  • 17.6. Centrix, Inc.
  • 17.7. Chengdu I-ReHealth Medical Devices Co., Ltd
  • 17.8. Dentsply Sirona Inc.
  • 17.9. DMG Dental
  • 17.10. GC Corporation
  • 17.11. Henry Schein, Inc.
  • 17.12. Laclede Products Company
  • 17.13. MEDICOM Group
  • 17.14. Ross Healthcare
  • 17.15. Sultan Healthcare, Inc.
  • 17.16. Ultradent Products, Inc.
  • 17.17. VOCO GmbH
  • 17.18. Young Dental Manufacturing Limited

LIST OF FIGURES

  • FIGURE 1. GLOBAL FLUORIDE FOAM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL FLUORIDE FOAM MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL FLUORIDE FOAM MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL FLUORIDE FOAM MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL FLUORIDE FOAM MARKET SIZE, BY APPLICATION MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL FLUORIDE FOAM MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL FLUORIDE FOAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL FLUORIDE FOAM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL FLUORIDE FOAM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL FLUORIDE FOAM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES FLUORIDE FOAM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA FLUORIDE FOAM MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL FLUORIDE FOAM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL FLUORIDE FOAM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL FLUORIDE FOAM MARKET SIZE, BY ANTICAVITY FOAM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL FLUORIDE FOAM MARKET SIZE, BY ANTICAVITY FOAM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL FLUORIDE FOAM MARKET SIZE, BY ANTICAVITY FOAM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL FLUORIDE FOAM MARKET SIZE, BY DESENSITIZING FOAM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL FLUORIDE FOAM MARKET SIZE, BY DESENSITIZING FOAM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL FLUORIDE FOAM MARKET SIZE, BY DESENSITIZING FOAM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL FLUORIDE FOAM MARKET SIZE, BY REGULAR FOAM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL FLUORIDE FOAM MARKET SIZE, BY REGULAR FOAM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL FLUORIDE FOAM MARKET SIZE, BY REGULAR FOAM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL FLUORIDE FOAM MARKET SIZE, BY APPLICATION MODE, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL FLUORIDE FOAM MARKET SIZE, BY RINSE-OFF SYSTEM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL FLUORIDE FOAM MARKET SIZE, BY RINSE-OFF SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL FLUORIDE FOAM MARKET SIZE, BY RINSE-OFF SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL FLUORIDE FOAM MARKET SIZE, BY TRAY SYSTEM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL FLUORIDE FOAM MARKET SIZE, BY TRAY SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL FLUORIDE FOAM MARKET SIZE, BY TRAY SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL FLUORIDE FOAM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL FLUORIDE FOAM MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL FLUORIDE FOAM MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL FLUORIDE FOAM MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL FLUORIDE FOAM MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL FLUORIDE FOAM MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL FLUORIDE FOAM MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL FLUORIDE FOAM MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL FLUORIDE FOAM MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL FLUORIDE FOAM MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL FLUORIDE FOAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL FLUORIDE FOAM MARKET SIZE, BY DENTAL HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL FLUORIDE FOAM MARKET SIZE, BY DENTAL HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL FLUORIDE FOAM MARKET SIZE, BY DENTAL HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL FLUORIDE FOAM MARKET SIZE, BY DRUGSTORES & PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL FLUORIDE FOAM MARKET SIZE, BY DRUGSTORES & PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL FLUORIDE FOAM MARKET SIZE, BY DRUGSTORES & PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL FLUORIDE FOAM MARKET SIZE, BY ONLINE STORES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL FLUORIDE FOAM MARKET SIZE, BY ONLINE STORES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL FLUORIDE FOAM MARKET SIZE, BY ONLINE STORES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL FLUORIDE FOAM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. AMERICAS FLUORIDE FOAM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 41. AMERICAS FLUORIDE FOAM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 42. AMERICAS FLUORIDE FOAM MARKET SIZE, BY APPLICATION MODE, 2018-2032 (USD MILLION)
  • TABLE 43. AMERICAS FLUORIDE FOAM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 44. AMERICAS FLUORIDE FOAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 45. NORTH AMERICA FLUORIDE FOAM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. NORTH AMERICA FLUORIDE FOAM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 47. NORTH AMERICA FLUORIDE FOAM MARKET SIZE, BY APPLICATION MODE, 2018-2032 (USD MILLION)
  • TABLE 48. NORTH AMERICA FLUORIDE FOAM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 49. NORTH AMERICA FLUORIDE FOAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 50. LATIN AMERICA FLUORIDE FOAM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. LATIN AMERICA FLUORIDE FOAM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 52. LATIN AMERICA FLUORIDE FOAM MARKET SIZE, BY APPLICATION MODE, 2018-2032 (USD MILLION)
  • TABLE 53. LATIN AMERICA FLUORIDE FOAM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 54. LATIN AMERICA FLUORIDE FOAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA FLUORIDE FOAM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA FLUORIDE FOAM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA FLUORIDE FOAM MARKET SIZE, BY APPLICATION MODE, 2018-2032 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA FLUORIDE FOAM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA FLUORIDE FOAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 60. EUROPE FLUORIDE FOAM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. EUROPE FLUORIDE FOAM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 62. EUROPE FLUORIDE FOAM MARKET SIZE, BY APPLICATION MODE, 2018-2032 (USD MILLION)
  • TABLE 63. EUROPE FLUORIDE FOAM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 64. EUROPE FLUORIDE FOAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 65. MIDDLE EAST FLUORIDE FOAM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. MIDDLE EAST FLUORIDE FOAM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 67. MIDDLE EAST FLUORIDE FOAM MARKET SIZE, BY APPLICATION MODE, 2018-2032 (USD MILLION)
  • TABLE 68. MIDDLE EAST FLUORIDE FOAM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 69. MIDDLE EAST FLUORIDE FOAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 70. AFRICA FLUORIDE FOAM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. AFRICA FLUORIDE FOAM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 72. AFRICA FLUORIDE FOAM MARKET SIZE, BY APPLICATION MODE, 2018-2032 (USD MILLION)
  • TABLE 73. AFRICA FLUORIDE FOAM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. AFRICA FLUORIDE FOAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC FLUORIDE FOAM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC FLUORIDE FOAM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC FLUORIDE FOAM MARKET SIZE, BY APPLICATION MODE, 2018-2032 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC FLUORIDE FOAM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC FLUORIDE FOAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL FLUORIDE FOAM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. ASEAN FLUORIDE FOAM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. ASEAN FLUORIDE FOAM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. ASEAN FLUORIDE FOAM MARKET SIZE, BY APPLICATION MODE, 2018-2032 (USD MILLION)
  • TABLE 84. ASEAN FLUORIDE FOAM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 85. ASEAN FLUORIDE FOAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 86. GCC FLUORIDE FOAM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GCC FLUORIDE FOAM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. GCC FLUORIDE FOAM MARKET SIZE, BY APPLICATION MODE, 2018-2032 (USD MILLION)
  • TABLE 89. GCC FLUORIDE FOAM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 90. GCC FLUORIDE FOAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPEAN UNION FLUORIDE FOAM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPEAN UNION FLUORIDE FOAM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPEAN UNION FLUORIDE FOAM MARKET SIZE, BY APPLICATION MODE, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPEAN UNION FLUORIDE FOAM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPEAN UNION FLUORIDE FOAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 96. BRICS FLUORIDE FOAM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. BRICS FLUORIDE FOAM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. BRICS FLUORIDE FOAM MARKET SIZE, BY APPLICATION MODE, 2018-2032 (USD MILLION)
  • TABLE 99. BRICS FLUORIDE FOAM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. BRICS FLUORIDE FOAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 101. G7 FLUORIDE FOAM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. G7 FLUORIDE FOAM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. G7 FLUORIDE FOAM MARKET SIZE, BY APPLICATION MODE, 2018-2032 (USD MILLION)
  • TABLE 104. G7 FLUORIDE FOAM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. G7 FLUORIDE FOAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 106. NATO FLUORIDE FOAM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. NATO FLUORIDE FOAM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. NATO FLUORIDE FOAM MARKET SIZE, BY APPLICATION MODE, 2018-2032 (USD MILLION)
  • TABLE 109. NATO FLUORIDE FOAM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. NATO FLUORIDE FOAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL FLUORIDE FOAM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. UNITED STATES FLUORIDE FOAM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 113. UNITED STATES FLUORIDE FOAM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. UNITED STATES FLUORIDE FOAM MARKET SIZE, BY APPLICATION MODE, 2018-2032 (USD MILLION)
  • TABLE 115. UNITED STATES FLUORIDE FOAM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. UNITED STATES FLUORIDE FOAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 117. CHINA FLUORIDE FOAM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 118. CHINA FLUORIDE FOAM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. CHINA FLUORIDE FOAM MARKET SIZE, BY APPLICATION MODE, 2018-2032 (USD MILLION)
  • TABLE 120. CHINA FLUORIDE FOAM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. CHINA FLUORIDE FOAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)